DR. Francisco Chio Jr. (from left), Director of the Chong Hua Hospital Mandaue-Heart and Vascular Institute (CHHM-HVI); Dr. Virgina Abalos, Medical Director of CHHM, and Dr. Maria Rosan Trani, Assistant Director of CHHM-HVI, lead the inauguration of a cardiovascular care facility on Saturday, Feb. 14. (Calvin Cordova)
CEBU CITY – Statistics showed that cardiovascular disease remains the leading cause of death in the Philippines.
With this, health experts welcomed the inauguration of the Heart and Vascular Institute of the Chong Hua Hospital Mandaue (CHHM) on Saturday, Feb. 14.
“This is defining moment not only for Chong Hua but for cardiovascular care in the country,” said Dr. Francisco Chio Jr., the director of the CHHM Heart and Vascular Institute.
The opening of the institute was described as a direct response to the growing demand, expanding capacity and access to advanced heart and vascular treatment, and enabling more patients to receive timely, comprehensive care closer to home.
Guided by the enduring principles of its parent organization, Association Benevola de Cebu Inc. (ABDCI) – service beyond self, responsible stewardship, and commitment to communities – the institute was designed as a single, coordinated ecosystem of care, integrating diagnostics, intervention, surgery, critical care, rehabilitation, and prevention within one purpose-built facility.
Spanning 2,998-square meters, the institute enables continuity across the entire cardiac care journey. At its core is a rare Hybrid Cath Lab platform, combining the Philips Azurion7 R3 Hybrid OR Suite and the Siemens Healthineers ARTIS Icono Cath Lab System, allowing minimally invasive and open procedures to be performed in the same environment without transferring patients.
This configuration supports faster decisions, safer workflows, and improved outcomes for complex cases.
Beyond procedures, the institute includes dialysis-ready Coronary Care Unit (CCU) beds, comprehensive cardiac rehabilitation services, and advanced diagnostic support, ensuring recovery and long-term prevention are embedded into care.
Chio added that the institute stands not as an endpoint, but as a beginning, signaling readiness to meet the nation's growing cardiovascular needs with foresight and scale.
During the inauguration, Dr. Joshua Brillantes, director of the Department of Health-Central Visayas (DOH-7) highlighted the importance of addressing cardiovascular diseases.
Brillantes emphasized that heart disease continues to be a significant concern in the Philippines, with hypertension being a major risk factor.
"Heart disease doesn’t discriminate," he said. "It affects people of all ages, and early intervention can make a significant difference.”
According to the Philippine Statistics Authority, ischemic heart disease is the leading cause of death in the Philippines in the first half of 2025 with 53,985 deaths, which accounts for 19.9 percent of all deaths nationwide.